Germany · Delayed Price · Currency is EUR CSPC Pharmaceutical Group Statistics
Total Valuation
FRA:CVG has a market cap or net worth of EUR 9.91 billion. The enterprise value is 9.00 billion.
| Market Cap | 9.91B |
| Enterprise Value | 9.00B |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | Oct 17, 2025 |
Share Statistics
| Current Share Class | 11.43B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.93% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 25.24% |
| Owned by Institutions (%) | 25.85% |
| Float | 7.79B |
Valuation Ratios
The trailing PE ratio is 20.39 and the forward PE ratio is 15.56.
| PE Ratio | 20.39 |
| Forward PE | 15.56 |
| PS Ratio | 3.16 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.50 |
| EV / Sales | 2.84 |
| EV / EBITDA | 13.46 |
| EV / EBIT | 17.90 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | n/a |
| Interest Coverage | 99.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 162,894 |
| Profits Per Employee | 25,237 |
| Employee Count | 21,400 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:CVG has paid 127.29 million in taxes.
| Income Tax | 127.29M |
| Effective Tax Rate | 20.70% |
Stock Price Statistics
The stock price has increased by +42.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +42.53% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 46.02 |
| Average Volume (20 Days) | 150 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:CVG had revenue of EUR 3.14 billion and earned 486.22 million in profits. Earnings per share was 0.04.
| Revenue | 3.14B |
| Gross Profit | 2.08B |
| Operating Income | 504.28M |
| Pretax Income | 614.84M |
| Net Income | 486.22M |
| EBITDA | 649.14M |
| EBIT | 504.28M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 1.16 billion in cash and 59.26 million in debt, giving a net cash position of 1.10 billion.
| Cash & Cash Equivalents | 1.16B |
| Total Debt | 59.26M |
| Net Cash | 1.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.17B |
| Book Value Per Share | 0.35 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.23%, with operating and profit margins of 16.07% and 15.49%.
| Gross Margin | 66.23% |
| Operating Margin | 16.07% |
| Pretax Margin | 19.59% |
| Profit Margin | 15.49% |
| EBITDA Margin | 20.68% |
| EBIT Margin | 16.07% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.06%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.06% |
| Dividend Growth (YoY) | -24.89% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 2.93% |
| Shareholder Yield | 5.99% |
| Earnings Yield | 4.91% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Oct 15, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |